BCM
CRL icon

BlueCrest Capital Management’s Charles River Laboratories CRL Stock Holding History

BlueCrest Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,006
Closed -$540K – 943
2017
Q1 		$540K Buy
+6,006
New +$510K 0.03% 416
2016
Q3 		– Sell
-3,013
Closed -$248K – 784
2016
Q2 		$248K Buy
+3,013
New +$248K 0.01% 742
2016
Q1 		– Sell
-51,949
Closed -$4.18M – 831
2015
Q4 		$4.18M Buy
+51,949
New +$3.75M 0.22% 136
2015
Q2 		– Sell
-17,671
Closed -$1.4M – 813
2015
Q1 		$1.4M Buy
+17,671
New +$1.3M 0.09% 318

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return